Searched for
STENT PLACEMENT
What really happens inside your arteries before a heart attack? Heart surgeon explains the most critical factor for staying safeUS-based heart surgeon Dr Jeremy London has drawn attention to what artery blockages truly look like by sharing real visuals of a nearly bl...
If you have diabetes or obesity, Delhi cardiologist urges you to get this one test done to know heart attack risksA Delhi cardiologist warns that normal cholesterol reports can be misleading. He emphasizes the ApoB test, which counts harmful particles i...
Health rounds: DNA researchers are warned to beware of hackersResearchers warn that publicly accessible DNA research is vulnerable to cyberattacks, risking privacy, scientific accuracy, and national se...
You know what’s a heart attack. But a leg attack?Most patients and many doctors are unable to diagnose this condition, called a leg attack. But if not treated in time, it can cost you a li...
Targeted drug therapy may be the future of treating coronary diseases: StudyScientists are on a mission to find out what causes coronary diseases.
Scientist uncover new potential drug to treat heart diseaseThe scientists looked at the building blocks needed to enable the unhealthy response.
Ixigo, Sahajanand Medical Tech, Keventer Agro get Sebi's go-ahead to float IPOsThese three companies, which filed their preliminary IPO papers with Sebi between August and September, obtained observation letter from th...
Stent maker Sahajanand Medical Tech files IPO papers with SebiThe company may consider a pre-IPO placement of equity shares aggregating up to Rs 185 crore. If such placement is undertaken, the fresh is...
Top stocks in focus on Friday, 22 September 2017Here is a list of top stocks that are likely to be in focus in today's trading session.
Study fine print before buying insurance policyRegardless of the ailment or the treatment given, coverage would be determined by the definition of “critical illness“ stated in the policy.
Fifteen stocks in focus on Thursday, 23 March 2017Delta Corp plans to raise up to Rs 750 crore through issue of equity shares or other securities via qualified institutional placement (QIP).
- Merck wins one more Vioxx case
Vioxx-maker Merck faces thousands of lawsuits nationwide over the once-popular painkiller, but the pharmaceutical giant’s strategy to fight...